2'-Deoxy-4-desmethylwyosine
CAS No.: 101803-00-3
A convenient synthon for the preparation on N-2-alkyl derivatives of 2'-deoxyguanosine.
2'-Deoxy-4-desmethylwyosine
5-Methyl-2'-deoxycytidine Hydrochloride
CAS No.: 838-07-3 (Free Base) 5241-10-1 (HCl Salt)
Modified nucleoside synthon.
2-Methyladenosine
CAS No.: 16526-56-0
Modified nucleoside synthon.
N6-Benzoyl-5'-O-(dimethoxytrityl)-8-oxo-2'-deoxyadenosine
CAS No.: 142979-41-7
Modified nucleoside synthon.
α-2'-Deoxyguanosine
CAS No.: 19916-78-0
Modified nucleoside synthon.
5-Ethynyl-2'-deoxyuridine
CAS No.: 61135-33-9
Modified nucleoside synthon.
1,3-Dimethylpseudouridine
CAS No.: 64272-68-0
Modified nucleoside synthon.
2'-O-Methyluridine
CAS No.: 2140-76-3
Modified nucleoside synthon.
5'-O-(Dimethoxytrityl)-N2-(dimethylaminomethylidene)-7-deaza-2'-deoxyguanosine
CAS No.: 111869-42-2
Modified nucleoside synthon.
5-Formylcytidine
CAS No.: 148608-53-1
Modified nucleoside synthon.
N6-Methyl-2'-deoxyadenosine
CAS No.: 2002-35-9
Useful methylated adenosine synthon.
2-Amino-2'-deoxyadenosine
CAS No.: 4546-70-7
Nucleoside synthon useful in duplex stabilisation.
3'-Deoxythymidine
CAS No.: 05.05.3416 00:00:00
Modified nucleoside synthon.
N4-[(Dimethylamino)methylidene]-5-[3-oxo-[[6-[(trifluroacetyl)amino]-hexyl]amino]-1-propenyl]-2'-deoxycytidine
Modified nucleoside synthon.
Cytidin-5-yl-methanesulfonate sodium salt hydrate
Modified nucleoside synthon.
3',5'-Di-O-acetyl-2'-deoxyguanosine
CAS No.: 69992-10-5
Modified nucleoside synthon.
3-Methylcytidine
Modified nucleoside synthon.
5-Hydroxy-2'-deoxycytidine
CAS No.: 52278-77-0
Nucleoside of interest due to occurrence as abnormal base residue in cellular DNA.
7-Methyl-7-deaza-2'-deoxyguanosine
CAS No.: 90358-21-7
Modified nucleoside synthon.
2-Thio-2'-deoxycytidine
CAS No.: 169557-13-5
Modified nucleoside synthon.
Added to basket
Modified Nucleosides
Modified nucleosides are useful building blocks for DNA and RNA synthesis because they can alter the stability, function, and utility of an oligo, making them useful for a variety of applications.
Our uniquely large collection of modified nucleosides offers a diversity of properties such as fluorescence (e.g., Pyrrolo-dC, NACR1-350), immunostimulation (e.g., 5-Amino-3-β-D-ribofuranosylthiazolo[4,5-d]pyrimidin-2,7(3H,6H)-dione, NACR1-366), enzyme inhibition (e.g., Tricyclic Nucleoside Monophosphate, NACR1-362), and altered base-pairing (2'-Deoxyisoguanosine, NACR1-071).
Highlights of modified nucleosides within our collection include:
- Bromo- and Iodo-modified nucleoside phosphoramidite precursors (Bromo: NACR1-001, NACR1-003; Iodo: NACR1-002, NACR1-004)
- 5-Hydroxymethyl-2'-deoxycytidine (NACN4-007), 5-Formyl-2’-deoxycytidine (NACN4-003), and 5-Hydroxy-2'-deoxycytidine (NACN4-004) for epigenetic studies
- Family of Pseudouridine analogues including Pseudouridine (Fermentation NACR1-348; Synthetic NACR1-368) and N1-Methypseudouridine (NACR1-311)
- Unnatural bases (dNaM, NACR1-304; d5SICS, NACR1-302) for expanding the genetic alphabet and “DNA damaged” nucleosides (e.g., 8-Oxo-2'-deoxyguanosine, NACR1-292; 8-Oxo-2'-deoxyadenosine, NACR1-291)